Events » Biomedical Cross-disciplinary Seminar Series | Lipoprotein(a) and...

Biomedical Cross-disciplinary Seminar Series | Lipoprotein(a) and Cardiovascular Risk

2022-23 Biomedical Cross-disciplinary Seminar Series focuses on cardiovascular disease
A human heart with a portion highlighted in red indicating heart disease
When: 
Thursday, January 19, 2023 - 12:00pm
Where: 
Contacts: 

Leigh Frame, PhD, MHS, CERT ’20

Assistant professor, Department of Clinical Research and Leadership, director, Integrative Medicine Programs, and executive director, Office of Integrative Medicine and Health

leighframe@gwu.edu | 202-994-0184


Janette Rodrigues

Administrative director, GW Office of Integrative Medicine and Health

jrodrigues@gwu.edu

Join us for the GW Biomedical Cross-disciplinary Seminar Series: Connecting Academic Research & Inquiry Across Disciplines. This virtual lecture series explores a new cross-disciplinary topic each year.  The goal is to promote networking and collaboration in translational health among researchers, health care providers, and policy makers from different disciplines to shift the paradigm—from seeking a cure to developing a strategy of prevention. The 2022-23 seminar series topic is cardiovascular disease.

This online lecture on "Lipoprotein(a) and Cardiovascular Risk" will be presented by Michelle L. O’Donoghue, MD, MPH, associate professor, Cardiovascular Medicine, Harvard Medical School, and Brigham and Women's Hospital, Division of Cardiovascular Medicine, at 12 p.m. on Thursday, January 19, 2022.  The author of numerous peer-reviewed publications, Dr. O’Donoghue’s research focuses on optimizing the management of acute coronary syndromes (heart attacks), the study of women and heart disease, the use of existing biomarkers for risk stratification, potential new therapeutic targets, as well as the discovery and evaluation of novel biomarkers using “omic”-based technology.

Dr. O'Donoghue is a Senior Investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, founded by Dr. Eugene Braunwald. Dr. O’Donoghue’s primary research focus is the design and conduct of multicenter clinical trials for patients with stable and unstable coronary disease with a focus on the study of women and heart disease. Additional clinical research interests include the evaluation of novel antiplatelet drugs, established and novel biomarkers and the development of novel therapeutics in the management of atherosclerosis and diabetes mellitus.